The Framingham Brain Donation Program: Neuropathology Along the Cognitive Continuum

被引:0
|
作者
Au, Rhoda [1 ,2 ]
Seshadri, Sudha [1 ,2 ]
Knox, Kristen [2 ]
Beiser, Alexa [1 ,2 ,3 ]
Himali, Jayandra J. [1 ,2 ,3 ]
Cabral, Howard J. [3 ]
Auerbach, Sanford [1 ,2 ]
Green, Robert C. [1 ]
Wolf, Philip A. [1 ,2 ]
McKee, Ann C. [1 ,4 ]
机构
[1] Boston Univ, Sch Med, Dept Neurol, Framingham Heart Study, Boston, MA 02118 USA
[2] NHLBI, Framingham Heart Study, Framingham, MA USA
[3] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA
[4] Bedford Vet Adm Hosp, Geriatr Res Educ Clin Ctr, Bedford, MA 01730 USA
关键词
Brain; autopsy; epidemiology; alzheimer's disease; brain ischemia; VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; EXECUTIVE DYSFUNCTION; CLINICAL-DIAGNOSIS; LIFETIME RISK; AMYLOID LOAD; DEMENTIA; IMPAIRMENT; PATHOLOGY; CRITERIA;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The Framingham Heart Study has enrolled 3 generations of participants, the Original cohort (Gen 1) enrolled in 1948, the Offspring cohort (Gen 2) enrolled in 1971 and the Third Generation enrolled in 2002. Participants have been undergoing prospective surveillance for incident stroke and dementia and embedded within this cohort is the voluntary Framingham Brain Donation Program that was begun in 1997. Participants who register to become brain donors have had one or more brain MR and cognitive test batteries administered. In addition, they undergo neurological evaluation as indicated, record review and post-mortem next-of-kin interview to determine the presence, type and extent of antemortem, clinical neurological diagnoses and to assign a retrospective Clinical Dementia Rating (CDR) Scale score. Between 1997 and 2009 there were 1806 deaths, 186 of which were among registered brain donors and of these 139 brains could be examined. 58% were deemed cognitively normal at death. We present results for 3 projects; the first was to examine the sensitivity and specificity of our clinical diagnosis against the gold standard of pathological AD in 59 persons who underwent detailed cognitive assessment in the two years prior to death; we observed a 77.3% sensitivity (2 persons with AD were diagnosed clinically as Lewy body dementia) and a 91.9% specificity. The second examined the correlation of regional Alzheimer-type pathology to cognitive status at death among 34 persons who were over the age of 75 and without any significant vascular or alternative neurodegenerative pathology and found that neurofibrillary tangle counts distinguished between persons who were controls, had mild cognitive impairment, mild or moderate dementia; tangles in dorsolateral frontal cortex best distinguished MCI and controls. The third project examined the extent and severity of vascular pathology, again in a larger sample of varying cognitive abilities and in a subsample of persons with either amnestic or non-amnestic MCI. We observed that an aggregate ischemic injury score was significantly higher in persons with a CDR score of 0.5 than in normal controls.
引用
收藏
页码:673 / 686
页数:14
相关论文
共 50 条
  • [41] Improving memory in Parkinson's disease: A healthy brain ageing cognitive training program
    Naismith, Sharon L.
    Mowszowski, Loren
    Diamond, Keri
    Lewis, Simon J. G.
    MOVEMENT DISORDERS, 2013, 28 (08) : 1097 - 1103
  • [42] Perceptions, Knowledge, Incentives, and Barriers of Brain Donation Among African American Elders Enrolled in an Alzheimer's Research Program
    Lambe, Susan
    Cantwell, Nicole
    Islam, Fareesa
    Horvath, Kathy
    Jefferson, Angela L.
    GERONTOLOGIST, 2011, 51 (01) : 28 - 38
  • [43] The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007
    Thomas G. Beach
    Lucia I. Sue
    Douglas G. Walker
    Alex E. Roher
    LihFen Lue
    Linda Vedders
    Donald J. Connor
    Marwan N. Sabbagh
    Joseph Rogers
    Cell and Tissue Banking, 2008, 9 : 229 - 245
  • [44] The Sun Health Research Institute Brain Donation Program: Description and experience, 1987-2007
    Beach, Thomas G.
    Sue, Lucia I.
    Walker, Douglas G.
    Roher, Alex E.
    Lue, LihFen
    Vedders, Linda
    Connor, Donald J.
    Sabbagh, Marwan N.
    Rogers, Joseph
    CELL AND TISSUE BANKING, 2008, 9 (03) : 229 - 245
  • [45] Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial
    O. Realdon
    F. Rossetto
    M. Nalin
    I. Baroni
    M. Cabinio
    R. Fioravanti
    F. L. Saibene
    M. Alberoni
    F. Mantovani
    M. Romano
    R. Nemni
    F. Baglio
    BMC Psychiatry, 16
  • [46] Brain donation in psychiatry: results of a Dutch prospective donor program among psychiatric cohort participants
    de lange, Geertje M.
    Rademaker, Marleen
    Boks, Marco P.
    Palmen, Saskia J. M. C.
    BMC PSYCHIATRY, 2017, 17
  • [47] Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial
    Realdon, O.
    Rossetto, F.
    Nalin, M.
    Baroni, I.
    Cabinio, M.
    Fioravanti, R.
    Saibene, F. L.
    Alberoni, M.
    Mantovani, F.
    Romano, M.
    Nemni, R.
    Baglio, F.
    BMC PSYCHIATRY, 2016, 16
  • [48] Randomized Controlled Trial of a Healthy Brain Ageing Cognitive Training Program: Effects on Memory, Mood, and Sleep
    Diamond, Keri
    Mowszowski, Loren
    Cockayne, Nicole
    Norrie, Louisa
    Paradise, Matthew
    Hermens, Daniel F.
    Lewis, Simon J. G.
    Hickie, Ian B.
    Naismith, Sharon L.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 44 (04) : 1181 - 1191
  • [49] Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers
    Paul Theo Zebhauser
    Achim Berthele
    Oliver Goldhardt
    Janine Diehl-Schmid
    Josef Priller
    Marion Ortner
    Timo Grimmer
    Alzheimer's Research & Therapy, 14
  • [50] Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study
    Snowden, Stuart G.
    Ebshiana, Amera A.
    Hye, Abdul
    An, Yang
    Pletnikova, Olga
    O'Brien, Richard
    Troncoso, John
    Legido-Quigley, Cristina
    Thambisetty, Madhav
    PLOS MEDICINE, 2017, 14 (03)